- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Chain A: N.50, S.51
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.50, A:S.51
NAG.5: 2 residues within 4Å:- Chain A: I.113, N.115
No protein-ligand interaction detected (PLIP)NAG.6: 4 residues within 4Å:- Chain A: N.184, T.186, Q.273, E.274
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.184, A:E.274, A:E.274
NAG.7: 5 residues within 4Å:- Chain A: I.284, N.286, M.313, S.314, R.561
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.561
NAG.10: 2 residues within 4Å:- Chain B: Y.48, N.50
No protein-ligand interaction detected (PLIP)NAG.11: 2 residues within 4Å:- Chain B: I.113, N.115
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.115, B:N.115
NAG.12: 4 residues within 4Å:- Chain B: N.184, T.186, Q.273, E.274
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.274
- Water bridges: B:T.186
NAG.13: 2 residues within 4Å:- Chain B: W.152, N.246
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.246
- 4 x SY1: 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE(Non-covalent)
SY1.8: 14 residues within 4Å:- Chain A: R.90, E.170, E.171, F.322, Y.512, W.594, S.595, Y.596, V.621, Y.627, Y.631, N.675, V.676, H.705
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:F.322, A:Y.596, A:V.621, A:Y.627, A:V.676
- Hydrogen bonds: A:R.90, A:E.170, A:Y.512, A:Y.596
- Water bridges: A:Y.627, A:Y.627
- pi-Stacking: A:Y.512, A:Y.631
SY1.9: 9 residues within 4Å:- Chain A: Q.88, E.156, D.157, F.205, K.215, T.216, V.217, R.218, V.219
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:K.215, A:K.215, A:V.217
- Hydrogen bonds: A:K.215, A:R.218, A:R.218
- Water bridges: A:Q.88
- pi-Stacking: A:F.205
- pi-Cation interactions: A:K.215
SY1.14: 14 residues within 4Å:- Chain B: R.90, E.170, E.171, F.322, Y.512, W.594, S.595, Y.596, V.621, Y.627, Y.631, N.675, V.676, H.705
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:F.322, B:Y.596, B:V.621, B:Y.627, B:Y.627, B:V.676
- Hydrogen bonds: B:R.90, B:E.170, B:Y.596
- pi-Stacking: B:Y.512, B:Y.631
SY1.15: 9 residues within 4Å:- Chain B: Q.88, E.156, D.157, F.205, K.215, T.216, V.217, R.218, V.219
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:V.217, B:V.217
- Hydrogen bonds: B:Q.88, B:K.215, B:R.218, B:R.218
- pi-Stacking: B:F.205
- pi-Cation interactions: B:K.215
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feng, J. et al., Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J.Med.Chem. (2007)
- Release Date
- 2008-03-04
- Peptides
- Dipeptidyl peptidase 4: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x SY1: 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feng, J. et al., Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J.Med.Chem. (2007)
- Release Date
- 2008-03-04
- Peptides
- Dipeptidyl peptidase 4: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B